(Joint program between USciences and The Wistar Institute)
This research training program is designed to train students for a successful academic or industrial career in cancer biology and therapy. This training will be achieved through a comprehensive, integrated graduate curriculum that leverages existing scientific excellence in basic and translational cancer research at The Wistar Institute and University of the Sciences (USciences).
The program is designed to fill a regional gap in specific training in cancer biology, including cutting-edge strategies in translational aspects, as well as hands-on training to emphasize the understanding of the process of drug discovery and therapy. The program will integrate the long tradition of multidisciplinary academic achievements in cancer biology at The Wistar Institute with the focus on drug discovery and industrial partnership of researchers at USciences.
The didactic program comprises core courses that will provide essential background in cell and molecular biology, biochemistry, and biotechnology as well as advanced graduate courses focusing on the basic mechanisms of cancer biology as well as drug discovery. Together, the approach integrates a learning platform combining up-to-date basic mechanistic understanding of cancer pathways with more translational, disease-relevant topics in cancer therapy and drug discovery. The curriculum is designed to equip students to succeed in a multidisciplinary environment as both hypothesis-driven academic cancer researchers and industrial or academic discoverers.
The degree requires completion of 27 didactic credits and at least 20 credits of research.